Assignee
BLOODWORKS
US·21 granted patents·13 pending applications·21 citations·filing 2013–2024
Top patents by PatentIndex Score
34 records- 0194US9903876B2Biochemical markers of red blood cell storage and toxicityBLOODWORKS·Filed 2017·Granted Feb 27, 2018·9 cites·12 claims
- 0286US10253109B2Antibodies that recognize red blood cell antigensBLOODWORKS·Filed 2015·Granted Apr 9, 2019·3 cites·15 claims
- 0385US11248060B2Antibodies that recognize red blood cell antigensBLOODWORKS·Filed 2019·Granted Feb 15, 2022·2 cites·18 claims
- 0484US2025011467A1Antibodies that recognize red blood cell antigensBLOODWORKS·Filed 2024·Application pending·0 cites
- 0583US10830777B2Biochemical predictors of red blood cell qualityBLOODWORKS·Filed 2016·Granted Nov 10, 2020·2 cites·8 claims
- 0683US10578627B2Biochemical markers of red blood cell storage and toxicityBLOODWORKS·Filed 2019·Granted Mar 3, 2020·1 cites·9 claims
- 0782US10345316B2Biochemical markers of red blood cell storage and toxicityBLOODWORKS·Filed 2018·Granted Jul 9, 2019·1 cites·10 claims
- 0879US10705093B2Determination of small-molecule thiols and disulfides: protein bound cys and total cysteine as biomarkers of oxidative stressBLOODWORKS·Filed 2015·Granted Jul 7, 2020·3 cites·20 claims
- 0977US12030956B2Antibodies that recognize red blood cell antigensBLOODWORKS·Filed 2022·Granted Jul 9, 2024·0 cites·13 claims
- 1071US11047868B2Biochemical markers of red blood cell storage and toxicityBLOODWORKS·Filed 2020·Granted Jun 29, 2021·0 cites·9 claims
- 1168US12584929B2Composition and methods for assessing sensitivity and specificity of antibody detection reagentsBLOODWORKS·Filed 2021·Granted Mar 24, 2026·0 cites·10 claims
- 1267US11892458B2Biochemical predictors of red blood cell qualityBLOODWORKS·Filed 2020·Granted Feb 6, 2024·0 cites·12 claims
- 1366US11693018B2Dicarboxylic acids and correlated compounds as a measure of red blood cell qualityBLOODWORKS·Filed 2020·Granted Jul 4, 2023·0 cites·15 claims
- 1466US10330668B2Biochemical markers of platelet storageBLOODWORKS·Filed 2014·Granted Jun 25, 2019·0 cites·12 claims
- 1564US2021308239A1Therapeutic induction of tolerance using recombinant cell surface antigensBLOODWORKS·Filed 2021·Application pending·0 cites
- 1661US10806695B2Protein stabilizing factorsBLOODWORKS·Filed 2019·Granted Oct 20, 2020·0 cites·19 claims
- 1760US11085937B2Composition and methods for assessing sensitivity and specificity of antibody detection reagentsBLOODWORKS·Filed 2016·Granted Aug 10, 2021·0 cites·13 claims
- 1860US2019265228A1Biochemical markers of platelet storageBLOODWORKS·Filed 2019·Application pending·0 cites
- 1958US10677781B2STEAP3 as a biochemical marker of red blood cell storage and toxicityBLOODWORKS·Filed 2019·Granted Jun 9, 2020·0 cites·10 claims
- 2058US10441531B2Protein stabilizing factorsBLOODWORKS·Filed 2013·Granted Oct 15, 2019·0 cites·25 claims
- 2154US10816557B2Dicarboxylic acids and correlated compounds as a measure of red blood cell qualityBLOODWORKS·Filed 2015·Granted Oct 27, 2020·0 cites·8 claims
- 2253US2019117694A1Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipientsBLOODWORKS·Filed 2018·Application pending·0 cites
- 2351US2020319199A1Determination of small-molecule thiols and disulfides: protein bound cys and total cysteine as biomarkers of oxidative stressBLOODWORKS·Filed 2020·Application pending·0 cites
- 2449US10785967B2Mice with a modified glucose-6-phosphate dehydrogenase geneBLOODWORKS·Filed 2016·Granted Sep 29, 2020·0 cites·10 claims
- 2549US2019046620A1Therapeutic induction of tolerance using recombinant cell surface antigensBLOODWORKS·Filed 2017·Application pending·0 cites
- 2648US2020060262A1Methods to reduce clot formation in cold-stored platelet productsBLOODWORKS·Filed 2019·Application pending·0 cites
- 2747US10274480B2Steap3 as a biochemical marker of red blood cell storage and toxicityBLOODWORKS·Filed 2015·Granted Apr 30, 2019·0 cites·12 claims
- 2845US2021041463A1Antibody screens using transgenic antigen(s)BLOODWORKS·Filed 2019·Application pending·0 cites
- 2944US2017202963A1Methods of Preventing Platelet Alloimmunization and Alloimmune Platelet Refractoriness and Induction of Tolerance in Transfused RecipientsBLOODWORKS·Filed 2015·Application pending·0 cites
- 3042US2017261489A1Antibody response phenotypingBLOODWORKS·Filed 2017·Application pending·0 cites
- 3138US2020132700A1Methods of predicting post-transfusion survival of red blood cellsBLOODWORKS·Filed 2017·Application pending·0 cites
- 3238US2020138950A1Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipientsBLOODWORKS·Filed 2017·Application pending·0 cites
- 3337US11181534B2Routine laboratory and point-of-care (POC) testing for hemostasisBLOODWORKS·Filed 2015·Granted Nov 23, 2021·0 cites·22 claims
- 3431US2016271179A1Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipientsBLOODWORKS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BLOODWORKS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →